Genetic counselling legislation and practice in cancer in EU Member States
European Journal of Public Health · 2024
DOI: 10.1093/eurpub/ckae093 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Public Health, 2024. Verfasst von J Matt McCrary und 41 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: European Union, Genetic Counseling, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAN.HEAL Consortium, European Union, Research Council of Lithuania Project.
Abstract (Originalsprache)
Background
Somatic and germline genetic alterations are significant drivers of cancer. Increasing integration of new technologies which profile these alterations requires timely, equitable and high-quality genetic counselling to facilitate accurate diagnoses and informed decision-making by patients and their families in preventive and clinical settings. This article aims to provide an overview of genetic counselling legislation and practice across European Union (EU) Member States to serve as a foundation for future European recommendations and action.
Methods
National legislative databases of all 27 Member States were searched using terms relevant to genetic counselling, translated as appropriate. Interviews with relevant experts from each Member State were conducted to validate legislative search results and provide detailed insights into genetic counselling practice in each country.
Results
Genetic counselling is included in national legislative documents of 22 of 27 Member States, with substantial variation in legal mechanisms and prescribed details (i.e. the ‘who, what, when and where’ of counselling). Practice is similarly varied. Workforce capacity (25 of 27 Member States) and genetic literacy (all Member States) were common reported barriers. Recognition and/or better integration of genetic counsellors and updated legislation and were most commonly noted as the ‘most important change’ which would improve practice.
Conclusions
This review highlights substantial variability in genetic counselling across EU Member States, as well as common barriers notwithstanding this variation. Future recommendations and action should focus on addressing literacy and capacity challenges through legislative, regulatory and/or strategic approaches at EU, national, regional and/or local levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Human Genetics, Hannover Medical School, Hannover, Germany.
- Cancer Centre, , Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
- Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
- European Alliance for Personalised Medicine, Brussels, Belgium.
- Institute for Epidemiology, Social Medicine, and Health System Research, Hannover Medical School, Hannover, Germany.
ORCID-Profile: Jeroen van Rooij, Joan Brunet, Miriam Dalmas, Hans Ehrencrona, Tim Ripperger
Förderung
- CAN.HEAL Consortium
- European Union
- Research Council of Lithuania Project
- Research Council of Lithuania
- AstraZeneca
Zitieren
APA
McCrary, J. M., Van Valckenborgh, E., Poirel, H. A., de Putter, R., van Rooij, J., Horgan, D., Dierks, M. L., Antonova, O., Brunet, J., Chirita-Emandi, A., Colas, C., Dalmas, M., Ehrencrona, H., Grima, C., Janavičius, R., Klink, B., Koczok, K., Krajc, M., Lace, B., …, & Bergmann, A. K. (2024). Genetic counselling legislation and practice in cancer in EU Member States. European Journal of Public Health. https://doi.org/10.1093/eurpub/ckae093
Vancouver
McCrary JM, Van Valckenborgh E, Poirel HA, de Putter R, van Rooij J, Horgan D, et al. Genetic counselling legislation and practice in cancer in EU Member States. European Journal of Public Health. 2024. doi:10.1093/eurpub/ckae093
BibTeX
@article{McCrary2024,
author = {McCrary, J Matt and Van Valckenborgh, Els and Poirel, Hélène A and de Putter, Robin and van Rooij, Jeroen and Horgan, Denis and Dierks, Marie-Luise and Antonova, Olga and Brunet, Joan and Chirita-Emandi, Adela and Colas, Chrystelle and Dalmas, Miriam and Ehrencrona, Hans and Grima, Claire and Janavičius, Ramūnas and Klink, Barbara and Koczok, Katalin and Krajc, Mateja and Lace, Baiba and Leitsalu, Liis and Mistrik, Martin and Paneque, Milena and Primorac, Dragan and Roetzer, Katharina M and Ronez, Joelle and Slámová, Lucie and Spanou, Elena and Stamatopoulos, Kostas and Stoklosa, Tomasz and Strang-Karlsson, Sonja and Szakszon, Katalin and Szczałuba, Krzysztof and Turner, Jacqueline and van Dooren, Marieke F and van Zelst-Stams, Wendy A G and Vassallo, Loredana-Maria and Wadt, Karin A W and Žigman, Tamara and Ripperger, Tim and Genuardi, Maurizio and Van den Bulcke, Marc and Bergmann, Anke Katharina},
title = {Genetic counselling legislation and practice in cancer in EU Member States},
journal = {European Journal of Public Health},
year = {2024},
doi = {10.1093/eurpub/ckae093}
}
EUVIMED